Generic drug lobby taps former BIO exec as new CEO

Taking stock of the drug industry, from the lab to the medicine chest

September 25, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Generic drug lobby taps former BIO exec as new CEO The group has been without an official leader since December 2022, even as challenges to the generics industry mount. By John Wilkerson and Rachel Cohrs Zhang STAT+ | Moderna is scolded by a U.K. trade group for offering kids $2,000 to participate in a Covid trial A U.K. trade group decided Moderna violated industry codes by failing to maintain high standards and bringing "discredit" upon the industry. By Ed Silverman STAT+ | The little-known Chinese biotech whose cancer drug beat Keytruda has global ambitions Little-known Chinese biotech Akeso partnered with Summit Therapeutics on a lung cancer immunotherapy that rivals Merck's Keytruda By Jonathan Wosen SEBASTIEN BOZON/AFP via Getty Images Ozempic linked to lower opioid overdose rate in those with diabetes, study shows The authors said the findings, while preliminary, suggest that Ozempic-type drugs "may have value in helping to prevent opioid overdoses." By Lev Facher STAT+ | Amgen scores late-stage trial success for eczema and myasthenia gravis treatments, but faces stiff competition The company reported positive late-stage trial results for antibody drugs rocatinlimab and Upliza, but competition remains stiff from other drugmakers. By Jonathan Wosen and Allison DeAngelis STAT+ | Can Anne Wojcicki save 23andMe? Shares, which once traded at $13, now change hands at just 35 cents, and it's not yet clear whether the CEO will succeed in taking the company private. By Matthew Herper

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser